Log in

NASDAQ:ARTLArtelo Biosciences Stock Price, Forecast & News

+0.09 (+7.44 %)
(As of 05/22/2020 04:00 PM ET)
Today's Range
Now: $1.30
50-Day Range
MA: $1.14
52-Week Range
Now: $1.30
Volume51,698 shs
Average Volume63,424 shs
Market Capitalization$4.46 million
P/E RatioN/A
Dividend YieldN/A
Artelo Biosciences, Inc., an ethical biopharmaceutical company, focuses on developing, licensing, and commercializing cannabinoid therapeutic treatments. Its products pipeline includes ART12.11, a cannabidiol composition for the treatment of inflammatory bowel disease, stroke, and rare/orphan diseases; ART26.12, an endocannabinoid transport protein (FABP5) inhibitor for the treatment of breast cancer, prostate cancer, and neuropathic and nociceptive pain; and ART27.13 for the treatment of cancer and cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was founded in 2011 and is based in La Jolla, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.85 out of 5 stars

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Current SymbolNASDAQ:ARTL



Sales & Book Value

Annual SalesN/A
Book Value$1.60 per share


Net Income$-2,170,000.00


Market Cap$4.46 million
Next Earnings Date7/20/2020 (Estimated)
OptionableNot Optionable

Receive ARTL News and Ratings via Email

Sign-up to receive the latest news and ratings for ARTL and its competitors with MarketBeat's FREE daily newsletter.

Artelo Biosciences (NASDAQ:ARTL) Frequently Asked Questions

How has Artelo Biosciences' stock been impacted by COVID-19 (Coronavirus)?

Artelo Biosciences' stock was trading at $1.01 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ARTL shares have increased by 28.7% and is now trading at $1.30. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Artelo Biosciences?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Artelo Biosciences in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Artelo Biosciences.

When is Artelo Biosciences' next earnings date?

Artelo Biosciences is scheduled to release its next quarterly earnings announcement on Monday, July 20th 2020. View our earnings forecast for Artelo Biosciences.

How were Artelo Biosciences' earnings last quarter?

Artelo Biosciences (NASDAQ:ARTL) released its quarterly earnings results on Tuesday, April, 14th. The company reported ($0.40) earnings per share for the quarter, topping the consensus estimate of ($0.53) by $0.13. View Artelo Biosciences' earnings history.

What price target have analysts set for ARTL?

1 brokerages have issued twelve-month price targets for Artelo Biosciences' stock. Their forecasts range from $8.00 to $8.00. On average, they expect Artelo Biosciences' stock price to reach $8.00 in the next twelve months. This suggests a possible upside of 515.4% from the stock's current price. View analysts' price targets for Artelo Biosciences.

Has Artelo Biosciences been receiving favorable news coverage?

Media stories about ARTL stock have been trending extremely negative on Sunday, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Artelo Biosciences earned a media sentiment score of -4.6 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the immediate future. View the latest news aboutArtelo Biosciences.

Are investors shorting Artelo Biosciences?

Artelo Biosciences saw a increase in short interest in May. As of May 15th, there was short interest totaling 25,200 shares, an increase of 31.9% from the April 30th total of 19,100 shares. Based on an average daily volume of 118,500 shares, the short-interest ratio is presently 0.2 days. Currently, 1.1% of the company's shares are short sold. View Artelo Biosciences' Current Options Chain.

Who are some of Artelo Biosciences' key competitors?

What other stocks do shareholders of Artelo Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Artelo Biosciences investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Agile Therapeutics (AGRX), Crispr Therapeutics (CRSP), Vaxart (VXRT), Amarin (AMRN), Armata Pharmaceuticals (ARMP), Carnival (CCL), Gilead Sciences (GILD) and QUALCOMM (QCOM).

Who are Artelo Biosciences' key executives?

Artelo Biosciences' management team includes the following people:
  • Mr. Gregory D. Gorgas, Pres, CEO, CFO, Treasurer, Sec. & Director (Age 56)
  • Mr. Peter Michael O'Brien, Sr. VP of European Operations (Age 41)
  • Dr. Steven D. Reich, Chief Medical Officer (Age 73)
  • Mr. Jason H. Baybutt, Sr. VP of Fin. (Age 47)

What is Artelo Biosciences' stock symbol?

Artelo Biosciences trades on the NASDAQ under the ticker symbol "ARTL."

How do I buy shares of Artelo Biosciences?

Shares of ARTL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Artelo Biosciences' stock price today?

One share of ARTL stock can currently be purchased for approximately $1.30.

How big of a company is Artelo Biosciences?

Artelo Biosciences has a market capitalization of $4.46 million. Artelo Biosciences employs 1 workers across the globe.

What is Artelo Biosciences' official website?

The official website for Artelo Biosciences is www.artelobio.com.

How can I contact Artelo Biosciences?

Artelo Biosciences' mailing address is 888 Prospect Street Suite 210, La Jolla CA, 92037. The company can be reached via phone at 760-943-1689 or via email at [email protected]

This page was last updated on 5/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.